期刊文献+

增液汤对2型糖尿病相关靶细胞治疗作用的拆方研究 被引量:1

Study on the Effect of ZengYe Decoction on Target Cell Therapy of Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的在细胞水平上对增液汤治疗2型糖尿病的药效作用进行拆方研究,分析其组方原理。方法采用棕榈酸诱导建立HepG2肝癌细胞、C2C12骨骼肌细胞、3T3-L1脂肪细胞的胰岛素抵抗模型,给予增液汤及其拆方组处理后,通过测定2-NBDG的荧光强度来评价各组对细胞糖摄取的影响。借助胰岛素试剂盒来研究增液汤及其拆方组对葡萄糖刺激的MIN6胰岛细胞胰岛素分泌的影响。结果增液汤中三味中药分别在不同的细胞模型上发挥促进糖摄取、胰岛素分泌的作用。在HepG2细胞上,三味药促进糖摄取的效果相差不大;在C2C12细胞上,君药玄参发挥显著促进糖摄取的作用;在3T3-L1细胞上,麦冬有显著的作用。在MIN6细胞上,君药玄参具有很好的促进胰岛素分泌的作用。结论增液汤的整体药效通过方中三味药共同发挥,君药玄参相较于其他两味药做出的贡献更大,但臣药生地、麦冬的作用也不可或缺,说明增液汤的组方依据是合理的。 OBJECTIVE To investigate the pharmacodynamic effect of ZengYe Decoction in the treatment of type 2 diabetes in vitro,and analyze the principle of prescription.METHODS The insulin resistance models of HepG2 hepatoma cells,C2C12 skelet al muscle cells and 3T3-L1 adipocytes were induced by palmitic acid.After treatment with ZengYe Decoction and its disassembled group,the effect of each group on cell glucose uptake was evaluated by measuring the fluorescence intensity of 2-NBDG.The effect of ZengYe Decoction and its disassembled group on insulin secretion of MIN6 islet cells stimulated by glucose was studied with the help of insulin kit.RESULTS The three traditional Chinese medicines in ZengYe Decoction play the role of promoting glucose uptake and insulin secretion in different cell models.On HepG2 cells,the effects of the three drugs on promoting sugar uptake were similar;On C2C12 cells,Radix Scrophulariae played a significant role in promoting sugar uptake;Ophiopogon japonicus had a significant effect on 3T3-L1 cells.On MIN6 cells,Radix Scrophulariae had a good effect on promoting insulin secretion.CONCLUSION The overall efficacy of ZengYe decoction is brought into play through the three drugs in the prescription.The monarch drug Radix Scrophulariae makes a greatercontribution than the other two drugs,but the role of the minister drug Rehmannia glutinosa and Ophiopogon japonicus is also indispensable,indicating the prescription basis of ZengYe Decoction is reasonable.
作者 王武阳 徐钧陶 戚进 WANG Wu-yang;XU Jun-tao;QI Jin(China Pharmaceutical University,Nanjing 210000,China)
机构地区 中国药科大学
出处 《海峡药学》 2022年第6期8-13,共6页 Strait Pharmaceutical Journal
基金 国家自然科学基金资助项目(81673555)。
关键词 2型糖尿病 增液汤 拆方 组方原理 Type 2 diabetes mellitus ZengYe Decoction Disassembled prescriptions Principle of composition
  • 相关文献

参考文献4

二级参考文献19

  • 1何柏涛.中药复方研究的思考[J].基层中药杂志,1996,10(2):3-4. 被引量:3
  • 2马德权,赵永爱.2型糖尿病胰岛素抵抗中医药研究进展[J].中国误诊学杂志,2006,6(11):2060-2061. 被引量:5
  • 3吴卫明.消渴证治一得[J].现代中医药,2007,27(1):32-33. 被引量:2
  • 4Kahn S E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes[ J]. Diabetologia, 2003, 46: 3. 被引量:1
  • 5David E Moller. New drug targets for type 2 diabetes and the metabolic syndrome[ R]. Nature, 2001, 414: 821. 被引量:1
  • 6Thripathy D, Carlsson M, Almgren P, et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: Lessons from the botnia study[ J]. Diabetes, 2000 ( 6 ) : 49. 被引量:1
  • 7Jay S. Diabetes Mellitus: Pathogenesis and Treatment Strategies[R]. J Med Chem, 2004, 47: 4113. 被引量:1
  • 8Muhammad A, Abdul G, Masafumi M, et al. The relative contributions of insulin resistance and beta cell failure to the transition from normal to impaired glucose tolerance varies in different ethnic groups [ J]. Diabetes & metabolic syndrome, 2007, 1: 105. 被引量:1
  • 9Chen W P, Chi T C, Chuang L M, et al. Resveratrol enhances insulin secretion by blocking KATP. and Kv channels of beta cells [ J ]. European Pharmacology, 2007, 568 : 269. 被引量:1
  • 10许济群.方剂学[M].上海:上海科学技术出版社,1993.118. 被引量:19

共引文献45

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部